HEADER TRANSFERASE 13-MAR-14 4CTH TITLE NEPRILYSIN VARIANT G399V,G714K IN COMPLEX WITH PHOSPHORAMIDON COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEPRILYSIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 52-750; COMPND 5 SYNONYM: ATRIOPEPTIDASE, COMMON ACUTE LYMPHOCYTIC LEUKEMIA ANTIGEN, COMPND 6 CALLA, ENKEPHALINASE, NEUTRAL ENDOPEPTIDASE 24.11, NEP, NEUTRAL COMPND 7 ENDOPEPTIDASE, SKIN FIBROBLAST ELASTASE, SFE, CD10; COMPND 8 EC: 3.4.24.11; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BAKER'S YEAST; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4932 KEYWDS TRANSFERASE, AMYLOID BETA, ALZHEIMER'S DISEASE, ENZYME ENGINEERING EXPDTA X-RAY DIFFRACTION AUTHOR C.I.WEBSTER,M.BURRELL,L.OLSSON,S.B.FOWLER,S.DIGBY,A.SANDERCOCK, AUTHOR 2 A.SNIJDER,J.TEBBE,U.HAUPTS,J.GRUDZINSKA,L.JERMUTUS,C.ANDERSSON REVDAT 5 20-DEC-23 4CTH 1 HETSYN REVDAT 4 29-JUL-20 4CTH 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 08-MAY-19 4CTH 1 REMARK LINK REVDAT 2 20-JUN-18 4CTH 1 REMARK REVDAT 1 13-AUG-14 4CTH 0 JRNL AUTH C.I.WEBSTER,M.BURRELL,L.OLSSON,S.B.FOWLER,S.DIGBY, JRNL AUTH 2 A.SANDERCOCK,A.SNIJDER,J.TEBBE,U.HAUPTS,J.GRUDZINSKA, JRNL AUTH 3 L.JERMUTUS,C.ANDERSSON JRNL TITL ENGINEERING NEPRILYSIN ACTIVITY AND SPECIFICITY TO CREATE A JRNL TITL 2 NOVEL THERAPEUTIC FOR ALZHEIMER'S DISEASE. JRNL REF PLOS ONE V. 9 04001 2014 JRNL REFN ESSN 1932-6203 JRNL PMID 25089527 JRNL DOI 10.1371/JOURNAL.PONE.0104001 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.48 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 42359 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2138 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.21 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.79 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3091 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.4115 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2920 REMARK 3 BIN R VALUE (WORKING SET) : 0.4097 REMARK 3 BIN FREE R VALUE : 0.4434 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.53 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 171 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5611 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 128 REMARK 3 SOLVENT ATOMS : 325 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.37 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.16090 REMARK 3 B22 (A**2) : -4.16090 REMARK 3 B33 (A**2) : 8.32170 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.332 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.268 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.212 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.260 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.212 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5859 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7926 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2063 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 184 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 827 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5859 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 753 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7005 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.73 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.93 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 RESIDUE TYPES WITHOUT CCP4 ATOM TYPE IN LIBRARY=NAG ZN GOL. REMARK 3 NUMBER OF ATOMS WITH PROPER CCP4 ATOM TYPE=5973. NUMBER WITH REMARK 3 APPROX DEFAULT CCP4 ATOM TYPE=90. NUMBER TREATED BY BAD NON- REMARK 3 BONDED CONTACTS=1. REMARK 4 REMARK 4 4CTH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1290059997. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.917 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42405 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 45.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 9.200 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 8.00 REMARK 200 R MERGE FOR SHELL (I) : 1.27000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 16.40 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1DMT REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROP, PH 7.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.29467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.64733 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 37.64733 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 75.29467 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -75.29467 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 41 REMARK 465 HIS A 42 REMARK 465 HIS A 43 REMARK 465 HIS A 44 REMARK 465 HIS A 45 REMARK 465 HIS A 46 REMARK 465 HIS A 47 REMARK 465 HIS A 48 REMARK 465 HIS A 49 REMARK 465 HIS A 50 REMARK 465 TYR A 51 REMARK 465 ASP A 52 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 324 O5 NAG A 753 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 199 -60.30 67.08 REMARK 500 ASN A 210 87.60 -157.27 REMARK 500 ASN A 309 -74.04 -67.65 REMARK 500 ALA A 462 -38.13 -39.40 REMARK 500 VAL A 541 75.94 -101.63 REMARK 500 LEU A 559 52.55 -92.71 REMARK 500 SER A 565 125.97 -170.68 REMARK 500 ASP A 678 54.28 -91.88 REMARK 500 VAL A 748 -75.62 -116.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1750 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 583 NE2 REMARK 620 2 HIS A 587 NE2 97.6 REMARK 620 3 GLU A 646 OE1 102.4 114.6 REMARK 620 4 RDF A1759 O2P 117.9 124.2 98.8 REMARK 620 N 1 2 3 REMARK 630 REMARK 630 MOLECULE TYPE: GLYCOPEPTIDE ENZYME INHIBITOR REMARK 630 MOLECULE NAME: N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)-L- REMARK 630 LEUCYL-L-TRYPTOPHAN REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 RDF A 1759 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: RHA LEU TRP REMARK 630 DETAILS: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 G399V G714K ARE ENGINEERED MUTATIONS DBREF 4CTH A 51 749 UNP P08473 NEP_HUMAN 52 750 SEQADV 4CTH HIS A 41 UNP P08473 EXPRESSION TAG SEQADV 4CTH HIS A 42 UNP P08473 EXPRESSION TAG SEQADV 4CTH HIS A 43 UNP P08473 EXPRESSION TAG SEQADV 4CTH HIS A 44 UNP P08473 EXPRESSION TAG SEQADV 4CTH HIS A 45 UNP P08473 EXPRESSION TAG SEQADV 4CTH HIS A 46 UNP P08473 EXPRESSION TAG SEQADV 4CTH HIS A 47 UNP P08473 EXPRESSION TAG SEQADV 4CTH HIS A 48 UNP P08473 EXPRESSION TAG SEQADV 4CTH HIS A 49 UNP P08473 EXPRESSION TAG SEQADV 4CTH HIS A 50 UNP P08473 EXPRESSION TAG SEQADV 4CTH VAL A 399 UNP P08473 GLY 400 ENGINEERED MUTATION SEQADV 4CTH LYS A 714 UNP P08473 GLY 715 ENGINEERED MUTATION SEQRES 1 A 709 HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS TYR ASP ASP SEQRES 2 A 709 GLY ILE CYS LYS SER SER ASP CYS ILE LYS SER ALA ALA SEQRES 3 A 709 ARG LEU ILE GLN ASN MET ASP ALA THR THR GLU PRO CYS SEQRES 4 A 709 THR ASP PHE PHE LYS TYR ALA CYS GLY GLY TRP LEU LYS SEQRES 5 A 709 ARG ASN VAL ILE PRO GLU THR SER SER ARG TYR GLY ASN SEQRES 6 A 709 PHE ASP ILE LEU ARG ASP GLU LEU GLU VAL VAL LEU LYS SEQRES 7 A 709 ASP VAL LEU GLN GLU PRO LYS THR GLU ASP ILE VAL ALA SEQRES 8 A 709 VAL GLN LYS ALA LYS ALA LEU TYR ARG SER CYS ILE ASN SEQRES 9 A 709 GLU SER ALA ILE ASP SER ARG GLY GLY GLU PRO LEU LEU SEQRES 10 A 709 LYS LEU LEU PRO ASP ILE TYR GLY TRP PRO VAL ALA THR SEQRES 11 A 709 GLU ASN TRP GLU GLN LYS TYR GLY ALA SER TRP THR ALA SEQRES 12 A 709 GLU LYS ALA ILE ALA GLN LEU ASN SER LYS TYR GLY LYS SEQRES 13 A 709 LYS VAL LEU ILE ASN LEU PHE VAL GLY THR ASP ASP LYS SEQRES 14 A 709 ASN SER VAL ASN HIS VAL ILE HIS ILE ASP GLN PRO ARG SEQRES 15 A 709 LEU GLY LEU PRO SER ARG ASP TYR TYR GLU CYS THR GLY SEQRES 16 A 709 ILE TYR LYS GLU ALA CYS THR ALA TYR VAL ASP PHE MET SEQRES 17 A 709 ILE SER VAL ALA ARG LEU ILE ARG GLN GLU GLU ARG LEU SEQRES 18 A 709 PRO ILE ASP GLU ASN GLN LEU ALA LEU GLU MET ASN LYS SEQRES 19 A 709 VAL MET GLU LEU GLU LYS GLU ILE ALA ASN ALA THR ALA SEQRES 20 A 709 LYS PRO GLU ASP ARG ASN ASP PRO MET LEU LEU TYR ASN SEQRES 21 A 709 LYS MET THR LEU ALA GLN ILE GLN ASN ASN PHE SER LEU SEQRES 22 A 709 GLU ILE ASN GLY LYS PRO PHE SER TRP LEU ASN PHE THR SEQRES 23 A 709 ASN GLU ILE MET SER THR VAL ASN ILE SER ILE THR ASN SEQRES 24 A 709 GLU GLU ASP VAL VAL VAL TYR ALA PRO GLU TYR LEU THR SEQRES 25 A 709 LYS LEU LYS PRO ILE LEU THR LYS TYR SER ALA ARG ASP SEQRES 26 A 709 LEU GLN ASN LEU MET SER TRP ARG PHE ILE MET ASP LEU SEQRES 27 A 709 VAL SER SER LEU SER ARG THR TYR LYS GLU SER ARG ASN SEQRES 28 A 709 ALA PHE ARG LYS ALA LEU TYR VAL THR THR SER GLU THR SEQRES 29 A 709 ALA THR TRP ARG ARG CYS ALA ASN TYR VAL ASN GLY ASN SEQRES 30 A 709 MET GLU ASN ALA VAL GLY ARG LEU TYR VAL GLU ALA ALA SEQRES 31 A 709 PHE ALA GLY GLU SER LYS HIS VAL VAL GLU ASP LEU ILE SEQRES 32 A 709 ALA GLN ILE ARG GLU VAL PHE ILE GLN THR LEU ASP ASP SEQRES 33 A 709 LEU THR TRP MET ASP ALA GLU THR LYS LYS ARG ALA GLU SEQRES 34 A 709 GLU LYS ALA LEU ALA ILE LYS GLU ARG ILE GLY TYR PRO SEQRES 35 A 709 ASP ASP ILE VAL SER ASN ASP ASN LYS LEU ASN ASN GLU SEQRES 36 A 709 TYR LEU GLU LEU ASN TYR LYS GLU ASP GLU TYR PHE GLU SEQRES 37 A 709 ASN ILE ILE GLN ASN LEU LYS PHE SER GLN SER LYS GLN SEQRES 38 A 709 LEU LYS LYS LEU ARG GLU LYS VAL ASP LYS ASP GLU TRP SEQRES 39 A 709 ILE SER GLY ALA ALA VAL VAL ASN ALA PHE TYR SER SER SEQRES 40 A 709 GLY ARG ASN GLN ILE VAL PHE PRO ALA GLY ILE LEU GLN SEQRES 41 A 709 PRO PRO PHE PHE SER ALA GLN GLN SER ASN SER LEU ASN SEQRES 42 A 709 TYR GLY GLY ILE GLY MET VAL ILE GLY HIS GLU ILE THR SEQRES 43 A 709 HIS GLY PHE ASP ASP ASN GLY ARG ASN PHE ASN LYS ASP SEQRES 44 A 709 GLY ASP LEU VAL ASP TRP TRP THR GLN GLN SER ALA SER SEQRES 45 A 709 ASN PHE LYS GLU GLN SER GLN CYS MET VAL TYR GLN TYR SEQRES 46 A 709 GLY ASN PHE SER TRP ASP LEU ALA GLY GLY GLN HIS LEU SEQRES 47 A 709 ASN GLY ILE ASN THR LEU GLY GLU ASN ILE ALA ASP ASN SEQRES 48 A 709 GLY GLY LEU GLY GLN ALA TYR ARG ALA TYR GLN ASN TYR SEQRES 49 A 709 ILE LYS LYS ASN GLY GLU GLU LYS LEU LEU PRO GLY LEU SEQRES 50 A 709 ASP LEU ASN HIS LYS GLN LEU PHE PHE LEU ASN PHE ALA SEQRES 51 A 709 GLN VAL TRP CYS GLY THR TYR ARG PRO GLU TYR ALA VAL SEQRES 52 A 709 ASN SER ILE LYS THR ASP VAL HIS SER PRO LYS ASN PHE SEQRES 53 A 709 ARG ILE ILE GLY THR LEU GLN ASN SER ALA GLU PHE SER SEQRES 54 A 709 GLU ALA PHE HIS CYS ARG LYS ASN SER TYR MET ASN PRO SEQRES 55 A 709 GLU LYS LYS CYS ARG VAL TRP MODRES 4CTH ASN A 144 ASN GLYCOSYLATION SITE MODRES 4CTH ASN A 324 ASN GLYCOSYLATION SITE MODRES 4CTH ASN A 627 ASN GLYCOSYLATION SITE HET NAG A 752 14 HET NAG A 753 14 HET NAG A 754 14 HET ZN A1750 1 HET GOL A1751 6 HET GOL A1752 6 HET GOL A1753 6 HET GOL A1754 6 HET GOL A1755 6 HET GOL A1756 6 HET GOL A1757 6 HET GOL A1758 6 HET RDF A1759 37 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZN ZINC ION HETNAM GOL GLYCEROL HETNAM RDF N-ALPHA-L-RHAMNOPYRANOSYLOXY(HYDROXYPHOSPHINYL)-L- HETNAM 2 RDF LEUCYL-L-TRYPTOPHAN HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN RDF PHOSPHORAMIDON FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 5 ZN ZN 2+ FORMUL 6 GOL 8(C3 H8 O3) FORMUL 14 RDF C23 H34 N3 O10 P FORMUL 15 HOH *325(H2 O) HELIX 1 1 SER A 58 MET A 72 1 15 HELIX 2 2 ASP A 81 ASN A 94 1 14 HELIX 3 3 ASN A 105 GLU A 123 1 19 HELIX 4 4 ILE A 129 ASN A 144 1 16 HELIX 5 5 ASN A 144 ARG A 151 1 8 HELIX 6 6 GLY A 153 LEU A 160 1 8 HELIX 7 7 PRO A 161 TYR A 164 5 4 HELIX 8 8 TRP A 166 THR A 170 5 5 HELIX 9 9 ASN A 172 TYR A 177 1 6 HELIX 10 10 THR A 182 GLY A 195 1 14 HELIX 11 11 SER A 227 CYS A 233 5 7 HELIX 12 12 THR A 234 ILE A 236 5 3 HELIX 13 13 TYR A 237 ARG A 260 1 24 HELIX 14 14 ASP A 264 THR A 286 1 23 HELIX 15 15 LYS A 288 ARG A 292 5 5 HELIX 16 16 ASP A 294 TYR A 299 1 6 HELIX 17 17 LEU A 304 PHE A 311 1 8 HELIX 18 18 SER A 321 SER A 331 1 11 HELIX 19 19 THR A 332 ASN A 334 5 3 HELIX 20 20 ALA A 347 THR A 359 1 13 HELIX 21 21 SER A 362 MET A 376 1 15 HELIX 22 22 ASP A 377 LEU A 382 5 6 HELIX 23 23 SER A 383 VAL A 399 1 17 HELIX 24 24 ALA A 405 MET A 418 1 14 HELIX 25 25 MET A 418 PHE A 431 1 14 HELIX 26 26 ALA A 432 GLU A 434 5 3 HELIX 27 27 SER A 435 LEU A 454 1 20 HELIX 28 28 ASP A 455 LEU A 457 5 3 HELIX 29 29 ASP A 461 ALA A 474 1 14 HELIX 30 30 ASP A 483 ASN A 488 1 6 HELIX 31 31 ASN A 488 TYR A 496 1 9 HELIX 32 32 GLU A 505 LYS A 524 1 20 HELIX 33 33 LEU A 525 GLU A 527 5 3 HELIX 34 34 GLY A 557 LEU A 559 5 3 HELIX 35 35 SER A 569 GLY A 576 1 8 HELIX 36 36 GLY A 576 HIS A 587 1 12 HELIX 37 37 GLY A 588 ASP A 590 5 3 HELIX 38 38 ASN A 592 ASN A 595 5 4 HELIX 39 39 THR A 607 ASN A 627 1 21 HELIX 40 40 TRP A 630 GLY A 634 5 5 HELIX 41 41 THR A 643 GLY A 669 1 27 HELIX 42 42 ASN A 680 TRP A 693 1 14 HELIX 43 43 ARG A 698 ASP A 709 1 12 HELIX 44 44 PRO A 713 ASN A 724 1 12 HELIX 45 45 SER A 725 HIS A 733 1 9 SHEET 1 AA 2 ARG A 102 GLY A 104 0 SHEET 2 AA 2 GLY A 695 TYR A 697 -1 O THR A 696 N TYR A 103 SHEET 1 AB 4 ASN A 201 ASP A 207 0 SHEET 2 AB 4 ASN A 210 ASP A 219 -1 N ASN A 210 O ASP A 207 SHEET 3 AB 4 ASP A 342 VAL A 345 1 O ASP A 342 N ILE A 216 SHEET 4 AB 4 LYS A 301 THR A 303 -1 O MET A 302 N VAL A 343 SHEET 1 AC 2 GLU A 314 ILE A 315 0 SHEET 2 AC 2 LYS A 318 PRO A 319 -1 O LYS A 318 N ILE A 315 SHEET 1 AD 3 LYS A 476 GLY A 480 0 SHEET 2 AD 3 GLN A 551 PRO A 555 1 O ILE A 552 N ARG A 478 SHEET 3 AD 3 PHE A 544 SER A 546 -1 O PHE A 544 N VAL A 553 SSBOND 1 CYS A 56 CYS A 61 1555 1555 2.04 SSBOND 2 CYS A 79 CYS A 734 1555 1555 2.04 SSBOND 3 CYS A 87 CYS A 694 1555 1555 2.08 SSBOND 4 CYS A 142 CYS A 410 1555 1555 2.04 SSBOND 5 CYS A 233 CYS A 241 1555 1555 2.06 SSBOND 6 CYS A 620 CYS A 746 1555 1555 2.06 LINK ND2 ASN A 144 C1 NAG A 752 1555 1555 1.69 LINK ND2 ASN A 324 C1 NAG A 753 1555 1555 1.26 LINK ND2 ASN A 627 C1 NAG A 754 1555 1555 1.29 LINK NE2 HIS A 583 ZN ZN A1750 1555 1555 1.98 LINK NE2 HIS A 587 ZN ZN A1750 1555 1555 1.97 LINK OE1 GLU A 646 ZN ZN A1750 1555 1555 1.95 LINK ZN ZN A1750 O2P RDF A1759 1555 1555 1.96 CISPEP 1 PRO A 561 PRO A 562 0 10.39 CRYST1 108.799 108.799 112.942 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009191 0.005307 0.000000 0.00000 SCALE2 0.000000 0.010613 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008854 0.00000